Amphastar Pharmaceuticals, Inc.

AMPH · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$160$138$91$63
Dep. & Amort.$57$42$29$27
Deferred Tax-$18-$14-$16$4
Stock-Based Comp.$24$20$18$19
Change in WC-$15-$24-$32-$2
Other Non-Cash$5$22-$1-$13
Operating Cash Flow$213$184$89$98
Investing Activities
PP&E Inv.-$41-$38-$24-$27
Net Acquisitions-$129-$506$0$0
Inv. Purchases-$77-$145-$36-$17
Inv. Sales/Matur.$126$39$28$19
Other Inv. Act.-$4$1-$1-$3
Investing Cash Flow-$125-$649-$33-$29
Financing Activities
Debt Repay.$10$526-$2$32
Stock Issued$0$0$0$0
Stock Repurch.-$85-$58-$40-$29
Dividends Paid$0$0$0$0
Other Fin. Act.-$6-$14$15-$40
Financing Cash Flow-$81$454-$26-$37
Forex Effect-$0-$0-$0-$0
Net Chg. in Cash$7-$12$30$32
Supplemental Information
Beg. Cash$145$156$127$95
End Cash$152$145$156$127
Free Cash Flow$172$145$65$71
Amphastar Pharmaceuticals, Inc. (AMPH) Financial Statements & Key Stats | AlphaPilot